Ozempic International Purchase Legalities: What U.S. Patients Need to Know in 2026

Is it legal to buy Ozempic from a foreign pharmacy?

CBP describes prohibited items as forbidden by law to enter the United States, and restricted items as needing a special license or permit from a federal agency before entry [2].

Ozempic is a prescription product, first approved on 5 December 2017 under application 209637 [1]. FDA warns about counterfeit Ozempic and about unapproved GLP-1 versions that do not go through FDA review before they are marketed [3].

What the approved Ozempic product is

Ozempic injection is indicated in adults with type 2 diabetes to improve glycemic control alongside diet and exercise, to reduce major adverse cardiovascular events in people with established cardiovascular disease, and to reduce sustained eGFR decline, end-stage kidney disease and cardiovascular death in people with chronic kidney disease [4].

Compounded semaglutide after the shortage

FDA announced on 21 February 2025 that the semaglutide injection shortage was resolved [5]. Enforcement discretion for state-licensed pharmacies and physicians ended after a court denied the compounders' injunction request on 24 April 2025; for outsourcing facilities, FDA said it would not act on shortage-dependent violations until 22 May 2025 [5].

A pharmacy may now compound semaglutide only for an individual patient on a prescription, and a product that is essentially a copy of an approved drug only rarely (FDA says it does not intend to act against four or fewer such prescriptions per calendar month) or when the prescriber documents a significant difference for that patient [5]. Outsourcing facilities generally cannot compound it from bulk substance, because semaglutide is on neither the bulks list nor the shortage list [5].

FDA says compounded drugs are not FDA approved, and it reports dosing errors with compounded injectable semaglutide, including patients measuring the wrong dose and doses above the label [3].